Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.03 (-7.82%)
Close on Nov 17, 2026Market cap $1.29MP/E –Yield –
Scinai Immunotherapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -633.6%, against 728.9% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -633.6% | −1362.5 |
| FY2024 | Dec 31, 2024 | 728.9% | – |
See a number that looks wrong?